Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Retinal Disease Clinical Trials

15 recruiting trials for Retinal Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
15
Total Trials
15
Recruiting Now
1
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06455384

The Genetics Navigator: Evaluating a Digital Platform for Genomics Health Services

Genetic testing (GT) (including targeted panels, exome and genome sequencing) is increasingly being used for patient care as it improves diagnosis and health outcomes. In spite of...

Sponsor: Unity Health TorontoEnrolling: 1703 locations
RECRUITINGNCT02435940

Inherited Retinal Degenerative Disease Registry

The My Retina Tracker® Registry is sponsored by the Foundation Fighting Blindness and is for people affected by one of the rare inherited retinal degenerative diseases studied by...

Sponsor: Foundation Fighting BlindnessEnrolling: 200001 location
RECRUITINGNCT01432847

Cell Collection to Study Eye Diseases

Background: \- Best Vitelliform Dystrophy (Best disease), Late-Onset Retinal Degeneration (L-ORD), and Age-Related Macular Degeneration (AMD) all affect the retina, the light...

Sponsor: National Eye Institute (NEI)Enrolling: 9301 location
RECRUITINGNCT03011541

Stem Cell Ophthalmology Treatment Study II

This study will evaluate the use of autologous bone marrow derived stem cells (BMSC) for the treatment of retinal and optic nerve damage or disease.

Sponsor: MD Stem CellsEnrolling: 5004 locations
RECRUITINGPhase 1 / Phase 2NCT06394232

Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

The goal of this clinical study is to evaluate the safety and efficacy of novel stem cell formulation in patients having Geographic Atrophy (GA) Secondary to Dry Age-related...

Sponsor: Eyestem Research Pvt. Ltd.Enrolling: 543 locations
RECRUITINGPhase 3NCT06305416

A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema

Macular edema in diabetes, defined as retinal thickening within two disc diameters of the center of the macula, results from retinal microvascular changes that compromise the...

Sponsor: Incepta Pharmaceuticals LtdEnrolling: 701 location
RECRUITINGNCT07149740

Data Gathering for A10900

The objective of this study is to gather Optical Coherence Tomography (OCT) data on normal and diseased eyes

Sponsor: Optos, PLCEnrolling: 1804 locations
RECRUITINGNCT03713268

Intraoperative OCT Guidance of Intraocular Surgery II

The overall five-year goals of the project are to develop novel technology to provide actionable new information through provision of live volumetric imaging during surgery,...

Sponsor: Duke UniversityEnrolling: 2621 location
RECRUITINGNCT07458516

Longitudinal Observational Study of Diabetic Retinopathy Progression in Type 2 Diabetes Patients

The purpose of this clinical study is to explore imaging, functional and systemic biomarkers of diabetic retinopathy (DR) progression, in Type 2 Diabetes (T2D) patients with...

Sponsor: Association for Innovation and Biomedical Research on Light and ImageEnrolling: 1001 location
RECRUITINGNCT06287645

Color Fundus Photograph With Experts Labelling

This trial aims to provide a digital retinal image dataset from Pakistan, graded by three specialists according to the severity of Diabetic Retinopathy. The dataset aims to...

Sponsor: Pakistan Council of Scientific and Industrial ResearchEnrolling: 500001 location
RECRUITINGNCT06074731

Diagnostic Possibilities in Ophthalmological Diseases Using Swept Source Optical Coherence Tomography

In this pilot study we want to investigate morphological features acquired by the novel image modality and gain information regarding disease pathomechanism, development and...

Sponsor: Johannes Kepler University of LinzEnrolling: 5001 location
RECRUITINGNCT01496625

National Eye Institute Biorepository for Retinal Diseases

Background: \- To understand diseases of the retina and the eye, information is needed about people with and without such diseases. Researchers want to study these people and...

Sponsor: National Eye Institute (NEI)Enrolling: 6501 location
RECRUITINGPhase 1NCT06455826

MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby)

A Phase 1 Open-Label, Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of Intravitreally Administered VP-001 in Participants with Confirmed PRPF31...

Sponsor: PYC TherapeuticsEnrolling: 125 locations
RECRUITINGPhase 2NCT06627179

Study to Evaluate Ultevursen in Subjects With Retinitis Pigmentosa (RP) Due to Mutations in Exon 13 of the USH2A Gene

The purpose of this Phase 2b study is to evaluate the safety and tolerability of ultevursen administered via intravitreal injection (IVT) in subjects with Retinitis Pigmentosa...

Sponsor: Laboratoires TheaEnrolling: 8120 locations
RECRUITINGPhase 1 / Phase 2NCT06852963

A Repeat-Dose, Open-Label, Two Arm Safety and Efficacy Study of Two Doses of VP-001 Administered Intravitreally in...

This is a Phase 1/2 repeat-dose, open-label, two-arm, parallel group safety and efficacy study of two doses of VP-001 (30 μg and 75 μg) in participants with confirmed PRPF31...

Sponsor: PYC TherapeuticsEnrolling: 166 locations